|
| 36929942 | Genome-wide analyses characterize shared heritability among cancers and identify novel cancer susceptibility regions. | J Natl Cancer Inst | 2023 |
| 36286845 | Common Germline Risk Variants Impact Somatic Alterations and Clinical Features across Cancers. | Cancer Res | 2023 |
| 35882562 | GWAS meta-analysis of 16 790 patients with Barrett's oesophagus and oesophageal adenocarcinoma identifies 16 novel genetic risk loci and provides insights into disease aetiology beyond the single marker level. | Gut | 2023 |
| 36541210 | One bite or two? A comparison of single bite and double bite opsy echniques in gastrointetinal endocopy (BITES). | | 2023 |
| 34187846 | Multitrait genetic association analysis identifies 50 new risk loci for gastro-oesophageal reflux, seven new loci for Barrett's oesophagus and provides insights into clinical heterogeneity in reflux diagnosis. | Gut | 2022 |
| 35709760 | eQTL Set-Based Association Analysis Identifies Novel Susceptibility Loci for Barrett Esophagus and Esophageal Adenocarcinoma. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 34531201 | Development and presentation of an objective risk stratification tool for healthcare workers when dealing with the COVID-19 pandemic in the UK: risk modelling based on hospitalisation and mortality statistics compared with epidemiological data. | BMJ Open | 2021 |
| 34355204 | Large-scale cross-cancer fine-mapping of the 5p15.33 region reveals multiple independent signals. | HGG Adv | 2021 |
| 33300568 | Germline variation in the insulin-like growth factor pathway and risk of Barrett's esophagus and esophageal adenocarcinoma. | Carcinogenesis | 2021 |
| 32442322 | Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. | | 2020 |
| 31748258 | Shared Genetic Etiology of Obesity-Related Traits and Barrett's Esophagus/Adenocarcinoma: Insights from Genome-Wide Association Studies. | Cancer Epidemiol Biomarkers Prev | 2020 |
| 31618768 | A feasibility trial of Acetic acid-targeted Biopsies versus nontargeted quadrantic biopsies during BArrett's surveillance: the ABBA trial. | Endoscopy | 2020 |
| 30716477 | No Association Between Vitamin D Status and Risk of Barrett's Esophagus or Esophageal Adenocarcinoma: A Mendelian Randomization Study. | Clin Gastroenterol Hepatol | 2019 |
| 31080232 | Gastroesophageal reflux disease and Barrett esophagus: an overview of evidence-based guidelines. | Polish Archives of Internal Medicine | 2019 |
| 27486097 | Germline variation in inflammation-related pathways and risk of Barrett's oesophagus and oesophageal adenocarcinoma. | Gut | 2017 |
| 28576294 | Development of quality indicators for endoscopic eradication therapies in Barrett's esophagus: the TREAT-BE (Treatment with Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. | Gastrointestinal Endoscopy | 2017 |
| 28570552 | Development of Quality Indicators for Endoscopic Eradication Therapies in Barrett's Esophagus: The TREAT-BE (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Consortium. | American Journal of Gastroenterology | 2017 |
| 27527254 | Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis. | Lancet Oncol | 2016 |
| 27236921 | Polymorphism in a lincRNA Associates with a Doubled Risk of Pneumococcal Bacteremia in Kenyan Children. | Am J Hum Genet | 2016 |
| 27659670 | Response to Feuerstein J et al. "Systematic Analysis and Critical Appraisal of the Quality of the Scientific Evidence and Conflicts of Interest in Practice Guidelines (2005-2013) for Barrett's Esophagus". doi:10.1007/s10620-016-4222-2. | Digestive Diseases and Sciences | 2016 |
| 25096604 | Estimates of benefits and harms of prophylactic use of aspirin in the general population. | Ann Oncol | 2015 |
| 25447851 | Polymorphisms near TBX5 and GDF7 are associated with increased risk for Barrett's esophagus. | Gastroenterology | 2015 |
| 25869390 | BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. | Am J Gastroenterol | 2015 |
| 25767103 | Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial. | Journal of Medical Screening | 2015 |
| 25424203 | Trefoil Factor Expression in a Human Model of the Early Stages of Barrett's Esophagus. | Digestive Diseases and Sciences | 2015 |
| 26397112 | Management of Barrett esophagus: a practical guide for clinicians based on the BADCAT and BoB CAT recommendations. | | 2015 |
| 26052782 | Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. | Am J Gastroenterol | 2015 |
| 25003214 | The correlation between reading and mathematics ability at age twelve has a substantial genetic component. | Nat Commun | 2014 |
| 24165758 | British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus. | Gut | 2014 |
| 23871474 | A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. | Biol Psychiatry | 2014 |
| 24550372 | The stem cell organisation, and the proliferative and gene expression profile of Barrett's epithelium, replicates pyloric-type gastric glands. | Gut | 2014 |
| 24950987 | Gefitinib for oesophageal cancer progressing after chemotherapy (COG): a phase 3, multicentre, double-blind, placebo-controlled randomised trial. | Lancet Oncology, The | 2014 |
| 23291585 | Common variants in the HLA-DRB1-HLA-DQA1 HLA class II region are associated with susceptibility to visceral leishmaniasis. | Nat Genet | 2013 |
| 23974872 | Genome-wide association analysis identifies 13 new risk loci for schizophrenia. | Nat Genet | 2013 |
| 24288218 | The field effect in Barrett's esophagus: can we use it for screening and surveillance? | Endoscopy | 2013 |
| 23439235 | Barrett's esophagus: evolutionary insights from genomics. | Gastroenterology | 2013 |
| 23266557 | Identification of lineage-uncommitted, long-lived, label-retaining cells in healthy human esophagus and stomach, and in metaplastic esophagus. | Gastroenterology | 2013 |
| 22265016 | RHBDF2 mutations are associated with tylosis, a familial esophageal cancer syndrome. | Am J Hum Genet | 2012 |
| 22306652 | Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. | Nat Genet | 2012 |
| 22542157 | Aspirin and NSAIDs; benefits and harms for the gut. | | 2012 |
| 22541573 | Does aspirin really reduce the risk of colon cancer? | Lancet, The | 2012 |
| 22961001 | Common variants at the MHC locus and at chromosome 16q24.1 predispose to Barrett's esophagus. | Nat Genet | 2012 |
| 22921186 | Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer. | European Journal of Cancer | 2012 |
| 22537613 | Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. | Gastroenterology | 2012 |
| 22951876 | Genetics of Barrett's: the bigger, the better. | American Journal of Gastroenterology | 2012 |
| 22716297 | Comparing virtual with conventional microscopy for the consensus diagnosis of Barrett's neoplasia in the AspECT Barrett's chemoprevention trial pathology audit. | Histopathology | 2012 |
| 23152243 | Surgery versus radical endotherapies for early cancer and high-grade dysplasia in Barrett's oesophagus. | | 2012 |
| 23129370 | Why is there a change in patterns of GE cancer? | Recent Results in Cancer Research | 2012 |
| 24693272 | Aspirin chemoprevention in barrett esophagus: is the risk worth the benefit? | Gastroenterology and Hepatology | 2012 |
| 22200839 | Barrett's metaplasia glands are clonal, contain multiple stem cells and share a common squamous progenitor. | Gut | 2012 |